PharmacyCodes



Ranisan en es it fr

Ranisan Brand names, Ranisan Analogs

Ranisan Brand Names Mixture

  • Tritec (ranitidine bismuth citrate salt)

Ranisan Chemical_Formula

C13H22N4O3S

Ranisan RX_link

http://www.rxlist.com/cgi/generic2/ranitbc.htm

Ranisan fda sheet

Ranisan FDA

Ranisan msds (material safety sheet)

Ranisan MSDS

Ranisan Synthesis Reference

B. J. Price et al., U.S. Pat. 4,128,658 (1978)

Ranisan Molecular Weight

314.405 g/mol

Ranisan Melting Point

69-70 oC

Ranisan H2O Solubility

24.7 mg/mL

Ranisan State

Solid

Ranisan LogP

1.93

Ranisan Dosage Forms

Capsule; Liquid; Solution; Tablet; Syrup

Ranisan Indication

Used in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD).

Ranisan Pharmacology

Ranitidine is a histamine H2-receptor antagonist similar to cimetidine and famotidine. An H2-receptor antagonist, often shortened to H2 antagonist, is a drug used to block the action of histamine on parietal cells in the stomach, decreasing acid production by these cells. These drugs are used in the treatment of dyspepsia, however their use has waned since the advent of the more effective proton pump inhibitors. Like the H1-antihistamines, the H2 antagonists are inverse agonists rather than true receptor antagonists.

Ranisan Absorption

Approximately 50% bioavailability orally.

Ranisan side effects and Toxicity

LD50=77mg/kg (orally in mice). Symptoms of overdose include muscular tremors, vomiting, and rapid respiration.

Ranisan Patient Information

PATIENT INFORMATION

Phenylketonurics: ZANTAC 25 EFFERdose Tablets contain phenylalanine 2.81 mg per 25 mg of ranitidine. ZANTAC 150 EFFERdose Tablets
contain phenylalanine 16.84 mg per 150 mg of ranitidine. ZANTAC EFFERdose Tablets should not be chewed, swallowed whole, or dissolved
on the tongue.

Ranisan Organisms Affected

Humans and other mammals